This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ESN | Ann: First Significant Revenue for Entellect | 10/11/16 | 13 | 6.8K | |||
|
|||||||
ESN | Ann: Trading Halt | 21/06/15 | 4 | 2.2K | |||
|
|||||||
ESN | Ann: Results of Extraordinary General Meeting | 28/05/15 | 0 | 696 | |||
|
|||||||
ESN | Ann: Addendum to Notice of Extraordinary General Meeting | 13/05/15 | 0 | 524 | |||
|
|||||||
ESN | Ann: Appendix 4C - quarterly | 30/04/15 | 0 | 621 | |||
|
|||||||
ESN | Ann: Share Consolidation Timetable | 12:22 | 0 | 801 | |||
|
|||||||
ESN | Ann: Despatch of Extraordinary General Meeting Materials | 28/04/15 | 0 | 422 | |||
|
|||||||
ESN | Ann: Notice of Extraordinary General Meeting | 26/04/15 | 4 | 2.3K | |||
|
See All Discussions